4.7 Article

Identifying the Metabolic Signatures of PPARD-Overexpressing Gastric Tumors

Journal

Publisher

MDPI
DOI: 10.3390/ijms23031645

Keywords

gastric cancer; PPARD; NMR spectroscopy; LC-MS; hyperpolarized [1-C-13] pyruvate MR spectroscopy; metabolomics; metabolites; metabolic imaging

Funding

  1. Pancreatic Cancer Action Network [16-65-BHAT]
  2. Cancer Prevention and Research Institute of Texas [RP180164]
  3. NCI [U01CA214263, R21CA185536, R01CA236905, R03CA235106]
  4. National Institute of Biomedical Imaging and Engineering [R21EB031217]
  5. NCI Division of Cancer Prevention PREVENT Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Biomarkers [75N91019D00021]
  6. Koch Foundation Genitourinary Medical Oncology Funds
  7. Neubauer Family Foundation
  8. MD Anderson Institutional Research Grants and Startup Funds
  9. Computational Cancer Biology Training Program postdoctoral fellowship (Cancer Prevention and Research Institute of Texas ) [RP170593]
  10. Texas Medical Center Digestive Diseases Center foundation seed fund [5P30DK056338-18]
  11. NIH/NCI Cancer Center Support Grant [P30CA016672]

Ask authors/readers for more resources

Peroxisome proliferator-activated receptor delta (PPARD) plays an essential role in cell metabolism, cell proliferation, inflammation, and tumorigenesis. This study investigated the metabolic changes regulated by PPARD in gastric tumor development. The findings suggest that PPARD overexpression leads to alterations in metabolite levels, particularly in inosine monophosphate, uracil, phenylalanine, glycine, isocitrate, inosine, adenosine monophosphate, UDP-glucose, and oxypurinol. Additionally, fatty acid oxidation was identified as a potential bioenergy source for PPARD-expressing gastric tumors.
Peroxisome proliferator-activated receptor delta (PPARD) is a nuclear receptor known to play an essential role in regulation of cell metabolism, cell proliferation, inflammation, and tumorigenesis in normal and cancer cells. Recently, we found that a newly generated villin-PPARD mouse model, in which PPARD is overexpressed in villin-positive gastric progenitor cells, demonstrated spontaneous development of large, invasive gastric tumors as the mice aged. However, the role of PPARD in regulation of downstream metabolism in normal gastric and tumor cells is elusive. The aim of the present study was to find PPARD-regulated downstream metabolic changes and to determine the potential significance of those changes to gastric tumorigenesis in mice. Hyperpolarized [1-C-13] pyruvate magnetic resonance spectroscopy, nuclear magnetic resonance spectroscopy, and liquid chromatography-mass spectrometry were employed for metabolic profiling to determine the PPARD-regulated metabolite changes in PPARD mice at different ages during the development of gastric cancer, and the changes were compared to corresponding wild-type mice. Nuclear magnetic resonance spectroscopy-based metabolomic screening results showed higher levels of inosine monophosphate (p = 0.0054), uracil (p = 0.0205), phenylalanine (p = 0.017), glycine (p = 0.014), and isocitrate (p = 0.029) and lower levels of inosine (p = 0.0188) in 55-week-old PPARD mice than in 55-week-old wild-type mice. As the PPARD mice aged from 10 weeks to 35 weeks and 55 weeks, we observed significant changes in levels of the metabolites inosine monophosphate (p = 0.0054), adenosine monophosphate (p = 0.009), UDP-glucose (p = 0.0006), and oxypurinol (p = 0.039). Hyperpolarized [1-C-13] pyruvate magnetic resonance spectroscopy performed to measure lactate flux in live 10-week-old PPARD mice with no gastric tumors and 35-week-old PPARD mice with gastric tumors did not reveal a significant difference in the ratio of lactate to total pyruvate plus lactate, indicating that this PPARD-induced spontaneous gastric tumor development does not require glycolysis as the main source of fuel for tumorigenesis. Liquid chromatography-mass spectrometry-based measurement of fatty acid levels showed lower linoleic acid, palmitic acid, oleic acid, and steric acid levels in 55-week-old PPARD mice than in 10-week-old PPARD mice, supporting fatty acid oxidation as a bioenergy source for PPARD-expressing gastric tumors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available